PTH and osteoporosis: By comprehensively considering the osteoporosis occurrence risk, PTH reduction level and other indicators, the range from 18.33 to 27.40 ng/ml may be an optimization for the VD threshold, which again supports the conclusion that the VD deficiency threshold should be assessed according to pathological situations and ethnicity rather than adhering to a single standard.